PRESENTATION

Q2 FY2022 — Presentation

Q2 FY2022PDF · 25 pages1.3 MB
Lam Research
Corporation
December quarter 2021 financial results
January 26, 2022

-- 1 of 25 --

L A M R E S E A R C H
Cautionary statement regarding forward-looking
statements
This presentation and the accompanying discussion contain “forward-looking statements” under U.S. securities laws. Forward-looking
statements include any statements that are not statements of historical fact. Examples of forward-looking statements include, but are not
limited to: (1) anticipated business, balance sheet, cash flow and financial measures and results, including guidance, whether on a GAAP or
non-GAAP basis; (2) economic, market, industry and industry segment expectations; (3) product performance and changes in market share or
customer demands; (4) our ability to successfully execute business, capital allocation, product and growth plans or strategies, or otherwise
deliver value for customers and stockholders; (5) the impact and expected duration of supply chain disruptions, and our ability to mitigate
them; (6) the impact of the COVID-19 pandemic on our operations and financial results, and our ability to mitigate operational and business
impacts caused by it; and (7) the impact of trade regulations, export controls and trade disputes. Forward-looking statements speak only as of
the date they are made and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed,
including: supply chain disruptions or manufacturing capacity constraints may limit our ability to manufacture and sell our products; trade
regulations, export controls, trade disputes and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or
regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the
actions of our customers and competitors may be inconsistent with our expectations; the severity, magnitude and duration of the COVID–19
pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of
operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact
our operations and revenue in affected areas; as well as the other factors discussed in our filings with the Securities and Exchange
Commission (“SEC”), including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 27,
2021 and our quarterly report on Form 10-Q for the quarter ended September 26, 2021. You should not place undue reliance on forward-
looking statements. Lam undertakes no obligation to update any forward-looking statements.

-- 2 of 25 --

L A M R E S E A R C H
Business review &
industry outlook
Tim Archer
President and Chief Executive Officer

-- 3 of 25 --

L A M R E S E A R C H
Revenue records in
all market segments
and every sub-
segment of CSBG
Market share gains in
etch and deposition
December quarter
results impacted by
unexpected supply
chain delays
Delivered record revenue and EPS in calendar
year 2021
EPS = earnings per share
EPS calculated on a non-GAAP basis. Reconciliations of U.S GAAP results to non-GAAP results can be found at the end of this presentation
CSBG = Customer Support Business Group

-- 4 of 25 --

L A M R E S E A R C H
Continued growth in WFE spending
Calendar year 2021 WFE of mid-$80 billion consistent
with prior commentary
Growth from powerful end-demand, rising device
complexity, strong semiconductor industry profitability,
and regional government support
Technology landscape continues to build with drivers
such as AI, IoT, Cloud, 5G and the upcoming metaverse
Calendar year 2022 spending expected in $100 billion
range, with strong growth across all market segments
WFE = wafer fabrication equipment

-- 5 of 25 --

L A M R E S E A R C H
CSBG continues to exceed expectations
~44,000
~50,000
~56,000
~61,000
~66,000
~75,000
2016 	2017 	2018 	2019 	2020 	2021
GROWING INSTALLED BASE UNITS Large and growing installed base key to
our product innovation process
Calendar year 2021 ending chamber count of
~75,000 units, up ~13% year-over-year
Revenue per chamber grew nearly twice the growth
of chamber count, at ~24% year-over-year
Expect calendar year 2022 to be another strong
growth year for CSBG

-- 6 of 25 --

L A M R E S E A R C H
2021 was a year of significant milestones
Vantex ™
• Fastest new etch product ramp in Lam history and set to double
revenue for this product in 2022
Vector ® DT
• Backside deposition PTOR at all 3D NAND customers for
>200-layer devices
Selective etch
• Leading-edge wins with our selective etch, strip and surface
treatment solutions, including for gate-all-around applications
and first win in DRAM
Critical bitline/spacer
• Increased deposition market share with application wins for
RC reduction and qualified at all leading nodes
PTOR = production tool of record
RC = resistance capacitance

-- 7 of 25 --

L A M R E S E A R C H
Preparing for another outstanding period of growth
+ Near term: Alleviate supply
constraints
+ Product momentum
+ Installed-base outperformance
+ Tremendous WFE demand
Great position for
calendar year 2022

-- 8 of 25 --

L A M R E S E A R C H
December quarter 2021
financial results &
March quarter 2022 outlook
Doug Bettinger
Executive Vice President and Chief Financial Officer

-- 9 of 25 --

L A M R E S E A R C H
CY 2021 REVENUE
CY 2021 EARNINGS PER SHARE*
$16.5B
CY 2020 revenue: $11.9B
$32.46
CY 2020 EPS*: $20.45
Calendar year highlights
*Data are presented on a non-GAAP basis. Reconciliations of U.S. GAAP results to non-GAAP results can be found at the end of this presentation.

-- 10 of 25 --

L A M R E S E A R C H
Q DEC'21 REVENUE
Q DEC'21 DEFERRED REVENUE
$4.23B
Q Sep'21 revenue: $4.30B
$1.46B
Q Sep'21 deferred revenue: $1.11B
December quarter highlights

-- 11 of 25 --

L A M R E S E A R C H
December quarter revenue mix
System revenue segments* 	Revenue by region
NVM = non-volatile memory
*Systems revenue includes equipment and equipment upgrade sales from etch, deposition, clean, and our Reliant® product line
Record level of logic/other revenue dollars
Memory
58%

-- 12 of 25 --

L A M R E S E A R C H
Q DEC’21 CSBG REVENUE
$1.49B
Q Sep'21 CSBG revenue: $1.38B
Q Dec'20 CSBG revenue: $1.15B
Customer Support Business Group
12th consecutive record
Reliant® quarter

-- 13 of 25 --

L A M R E S E A R C H
Q DEC'21 	Q SEP'21
Revenue 	$4,227M 	$4,304M
Non-GAAP Gross Margin* 	46.8% 	46.0%
Non-GAAP Operating Expenses* 	$627M 	$586M
Non-GAAP Operating Income* 	$1,352M 	$1,393M
Non-GAAP Operating Income as a percentage of Revenue* 	32.0% 	32.4%
Non-GAAP Other Income (Expense), Net* 	$19M 	$(36)M
U.S. GAAP Diluted EPS 	$8.44 	$8.27
Non-GAAP Diluted EPS* 	$8.53 	$8.36
Diluted Share Count 	142M 	143M
December quarter financial results
*A reconciliation of U.S. GAAP results to non-GAAP results can be found at the end of this presentation.

-- 14 of 25 --

L A M R E S E A R C H
Key balance sheet and financial metrics
Q DEC'21 	Q SEP'21
Total Consolidated Gross Cash Balance 	$5,580M 	$4,863M
Account Receivables, Net 	$3,403M 	$3,397M
DSO 	73 Days 	72 Days
Inventories 	$3,074M 	$2,872M
Inventory Turns 	2.9 	3.2
Deferred Revenue* 	$1,458M 	$1,110M
Capital Expenditures 	$138M 	$136M
Equity Compensation Expense 	$63M 	$58M
Amortization Expense 	$20M 	$19M
Depreciation Expense 	$62M 	$61M
Share Repurchases 	$430M 	$1,210M
Cash Dividends 	$211M 	$185M
Headcount 	~16,300 	~15,400
*Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance.
Estimated future revenue from shipments to customers in Japan was approximately $328M as of December 26, 2021 and $331M as of September 26, 2021.

-- 15 of 25 --

L A M R E S E A R C H
March 2022
quarter guidance
$4.25B +/- $300M
Revenue
45.0% +/- 1%
Non-GAAP gross margin
29.5% +/- 1%
Non-GAAP operating margin
$7.45 +/- $0.75
Non-GAAP earnings per share*
A reconciliation of U.S. GAAP projected results to non-GAAP projected results can be found at the end of this presentation
*Based on a diluted share count of approximately 141 Million shares

-- 16 of 25 --

L A M R E S E A R C H
Q&A

-- 17 of 25 --

L A M R E S E A R C H
Appendix – reconciliation
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Three Months Ended
December 26,
2021
September 26,
2021
U.S. GAAP net income 	$ 	1,194,830 	$ 	1,179,744
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 	1,092 	1,092
Elective deferred compensation ("EDC") related liability valuation (decrease) increase - cost of goods sold 	(8) 	1,896
EDC related liability valuation (decrease) increase - research and development 	(15) 	3,412
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 	12,357 	12,357
EDC related liability valuation (decrease) increase - selling, general and administrative 	(10) 	2,275
Amortization of note discounts - other income (expense), net 	689 	683
Loss (Gain) on EDC related asset - other income (expense), net 	56 	(7,437)
Net income tax benefit on non-GAAP items 	(1,651) 	(2,461)
Non-GAAP net income 	$ 	1,207,340 	$ 	1,191,561
Non-GAAP net income per diluted share 	$ 	8.53 	$ 	8.36
U.S. GAAP net income per diluted share 	$ 	8.44 	$ 	8.27
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 	141,530 	142,612

-- 18 of 25 --

L A M R E S E A R C H
Twelve Months Ended
December 26,
2021
December 27,
2020
U.S. GAAP net income 	$ 	4,590,352 	$ 	2,964,134
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 	4,368 	5,794
Elective deferred compensation ("EDC") related liability valuation increase - cost of goods sold 	8,130 	7,040
Product rationalization - cost of goods sold 	5,774 	—
EDC related liability valuation increase - research and development 	14,633 	12,672
Product rationalization - research and development 	426 	—
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 	49,428 	49,428
EDC related liability valuation increase - selling, general and administrative 	9,772 	8,448
Amortization of note discounts - other income (expense), net 	3,293 	3,900
Gain on EDC related asset - other income (expense), net 	(32,085) 	(29,441)
Net income tax benefit on non-GAAP items 	(10,447) 	(10,786)
Income tax benefit on the conclusion of certain tax matters 	— 	(276)
Cumulative income tax benefit reversal due to a court ruling 	— 	(821)
Non-GAAP net income 	$ 	4,643,644 	$ 	3,010,092
Non-GAAP net income per diluted share 	$ 	32.46 	$ 	20.45
U.S. GAAP net income per diluted share 	$ 	32.09 	$ 	20.14
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 	143,066 	147,185
U.S. GAAP and non-GAAP revenue 	$ 	16,523,902 	$ 	11,928,806
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Appendix – reconciliation

-- 19 of 25 --

L A M R E S E A R C H
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited)
Three Months Ended
December 26,
2021
September 26,
2021
U.S. GAAP gross margin 	$ 	1,977,916 	$ 	1,976,754
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations 	1,092 	1,092
EDC related liability valuation (decrease) increase 	(8) 	1,896
Non-GAAP gross margin 	$ 	1,979,000 	$ 	1,979,742
U.S. GAAP gross margin as a percentage of revenue 	46.8 % 	45.9 %
Non-GAAP gross margin as a percentage of revenue 	46.8 % 	46.0 %
U.S. GAAP operating expenses 	$ 	639,777 	$ 	604,521
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations 	(12,357) 	(12,357)
EDC related liability valuation decrease (increase) 	25 	(5,687)
Non-GAAP operating expenses 	$ 	627,445 	$ 	586,477
U.S. GAAP operating income 	$ 	1,338,139 	$ 	1,372,233
Non-GAAP operating income 	$ 	1,351,555 	$ 	1,393,265
U.S. GAAP operating income as percent of revenue 	31.7 % 	31.9 %
Non-GAAP operating income as a percent of revenue 	32.0 % 	32.4 %
Appendix – reconciliation

-- 20 of 25 --

L A M R E S E A R C H
Reconciliation of U.S. GAAP Other Income (Expense), Net to Non-GAAP Other Income (Expense), Net
(in thousands)
(unaudited)
Three Months Ended
December 26,
2021
September 26,
2021
U.S. GAAP Other income (expense), net 	$ 	17,999 	$ 	(28,857)
Pre-tax non-GAAP items:
Amortization of note discounts 	689 	683
Loss (gain) on EDC related asset 	56 	(7,437)
Non-GAAP Other income (expense), net 	$ 	18,744 	$ 	(35,611)
Appendix – reconciliation

-- 21 of 25 --

L A M R E S E A R C H
Calculation of Free Cash Flows
(in thousands)
(unaudited)
Three Months Ended
Twelve Months
Ended
March 28,
2021
June 27,
2021
September 26,
2021
December 26,
2021
December 26,
2021
U.S. GAAP net cash provided by operating activities 	$ 	1,165,080 	$ 	1,435,935 	$ 	457,524 	$ 	1,440,506 	$ 	4,499,045
U.S. GAAP cash used for capital expenditures and intangible assets 	(89,596) 	(104,622) 	(136,427) 	(138,493) 	(469,138)
Total free cash flow 	$ 	1,075,484 	$ 	1,331,313 	$ 	321,097 	$ 	1,302,013 	$ 	4,029,907
Appendix – reconciliation

-- 22 of 25 --

L A M R E S E A R C H
Reconciliation of U.S. GAAP Income Tax Rate to Non-GAAP Income Tax Rate
(in thousands, except percentages)
(unaudited)
Three Months Ended
December 26,
2021
September 26,
2021
U.S. GAAP income before income taxes 	$ 	1,356,138 	$ 	1,343,376
U.S. GAAP income tax expense 	$ 	161,308 	$ 	163,632
U.S. GAAP income tax rate 	11.9 % 	12.2 %
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold 	$ 	1,092 	$ 	1,092
Elective deferred compensation ("EDC") related liability valuation (decrease) increase - cost of goods sold 	(8) 	1,896
EDC related liability valuation (decrease) increase - research and development 	(15) 	3,412
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative 	12,357 	12,357
EDC related liability valuation (decrease) increase - selling, general and administrative 	(10) 	2,275
Amortization of note discounts - other income (expense), net 	689 	683
Loss (Gain) on EDC related asset - other income (expense), net 	56 	(7,437)
Non-GAAP income before taxes 	$ 	1,370,299 	$ 	1,357,654
Net income tax benefit on non-GAAP items 	$ 	1,651 	$ 	2,461
Non-GAAP income tax expense 	$ 	162,959 	$ 	166,093
Non-GAAP income tax rate 	11.9 % 	12.2 %
Appendix – reconciliation

-- 23 of 25 --

L A M R E S E A R C H
Reconciliation of U.S. GAAP to Non-GAAP Guidance for the
quarter ended March 27, 2022
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential
impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments,
or other significant arrangements that may be completed or recognized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only
those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling
items included above are as follows:
• Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $1 million.
• Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $13 million.
• Net income per diluted share - amortization related to intangible assets acquired though business combinations, $13 million; amortization of note discounts, $1
million; and associated tax benefit for non-GAAP items ($2 million); totaling $12 million.
U.S. GAAP 	Reconciling Items 	Non-GAAP
Revenue 	$4.25 Billion 	+/- 	$300 Million 	— 	$4.25 Billion 	+/- 	$300 Million
Gross margin as a percentage of revenue 	45.0% 	+/- 	1% 	$ 	1 Million 	45.0% 	+/- 	1%
Operating income as a percentage of revenue 	29.2% 	+/- 	1% 	$ 	13 Million 	29.5% 	+/- 	1%
Net income per diluted share 	$7.36 	+/- 	$0.75 	$ 	12 Million 	$7.45 	+/- 	$0.75
Diluted share count 	141 Million 	— 	141 Million
Appendix – reconciliation

-- 24 of 25 --



-- 25 of 25 --